Search Ontology:
ChEBI

dapagliflozin

Term ID
CHEBI:85078
Synonyms
  • (1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
  • (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol
  • BMS 512148
  • BMS-512148
  • dapagliflozin
Definition
A C-glycosyl comprising β-D-glucose in which the anomeric hydroxy group is replaced by a 4-chloro-3-(4-ethoxybenzyl)phenyl group. Used (in the form of its propanediol monohydrate) to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes.
References
  • cas:461432-26-8
  • drugbank:DB06292
  • drugcentral:4304
  • kegg.drug:D08897
  • pmc:PMC10706647
  • pubmed:20509715
  • pubmed:23724409
  • pubmed:24840612
  • pubmed:25200570
  • pubmed:25351341
  • pubmed:25418019
  • pubmed:25421015
  • pubmed:25438821
  • pubmed:25516459
  • pubmed:25557661
  • pubmed:25560982
  • pubmed:25592197
  • pubmed:25609661
  • pubmed:25648671
  • pubmed:25671589
  • pubmed:25678954
  • pubmed:25688892
  • pubmed:25688893
  • pubmed:25694411
  • pubmed:25710563
  • pubmed:30000030
  • pubmed:32454718
  • pubmed:33859839
  • pubmed:35272683
  • pubmed:37113469
  • pubmed:37549309
  • pubmed:37664712
  • pubmed:37758208
  • pubmed:37895841
  • pubmed:37931629
  • pubmed:37936747
  • pubmed:37979161
  • pubmed:38017482
  • pubmed:38031729
  • pubmed:38044448
  • pubmed:38094412
  • pubmed:38097862
  • pubmed:38117458
  • pubmed:38124408
  • pubmed:38128857
  • pubmed:38133155
  • pubmed:38137545
  • pubmed:38170280
  • pubmed:38171497
  • pubmed:38171852
  • pubmed:38185119
  • pubmed:38220410
  • reaxys:11966426
  • wikipedia.en:Dapagliflozin
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from dapagliflozin
Phenotype where environments contain dapagliflozin
Phenotype modified by environments containing dapagliflozin
Phenotype affecting dapagliflozin
Human Disease Model